Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aurinia Pharm Ord (NQ: AUPH )

13.00 USD +0.36 (+2.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,993,029
Open 12.60
Bid (Size) 13.01 (3)
Ask (Size) 13.02 (3)
Prev. Close 12.64
Today's Range 12.45 - 13.01
52wk Range 9.720 - 20.50
Shares Outstanding 128,156,427
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
June 14, 2021
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) announced today the appointment of Dr. Brinda Balakrishnan, M.D., Ph.D., to the Company’s Board of Directors effective... 
From Business Wire News Releases
Aurinia Announces Results of the 2021 Annual General Meeting
June 07, 2021
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”) is pleased to announce that the eight incumbent directors of the Company were elected at the Company’s annual general... 
From Business Wire News Releases

Performance

YTD
-3.99%
-3.99%
1 Month
+1.40%
+1.40%
3 Month
-4.69%
-4.69%
6 Month
-0.23%
-0.23%
1 Year
-21.21%
-21.21%

More News

Read More
Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress
June 07, 2021
From Business Wire News Releases
venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences
June 03, 2021
From Business Wire News Releases
Interesting AUPH Put And Call Options For August 20th
June 18, 2021
Tags Stocks
From Market News Video
Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
May 27, 2021
From Business Wire News Releases
Aurinia To Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS™ (voclosporin) in Subjects with Lupus Nephritis
May 20, 2021
From Business Wire News Releases
How The Pieces Add Up: BIB Headed For $105
June 04, 2021
Tags ETFs
From ETF Channel
Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences
May 14, 2021
From Business Wire News Releases
Unusual Options Activity Insight: Aurinia Pharmaceuticals
June 03, 2021
Tags Options Markets Market News
From Benzinga
Aurinia's Lupkynis Shows Sustained Renal Response Rates In Lupus Nephritis Patients
May 21, 2021
Tags General Health Care Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media